Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 24 Colorectal Neoplasms 12 Colonic Neoplasms 9 Rectal Neoplasms 6 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Biliary Tract Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Gallbladder Neoplasms 3 Esophageal Neoplasms 3 HER2-positive Gastric Cancer 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Stage IA Pancreatic Adenocarcinoma 1 Solid Tumor 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Malignant Neoplasms of Digestive Organs 1 Lung Neoplasms 1 Klatskin Tumor 1 Immunotherapy 1 Gastric Adenocarcinoma 1 Fruquintinib 1 For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method 1

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Tegafur × Clear all

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡